May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Samuel Hume on FDA approvals Q1 2025: New antibiotics, ADCs for breast cancer and first pain medication targeting NaV1.8 sodium channel
Apr 20, 2025, 19:13

Samuel Hume on FDA approvals Q1 2025: New antibiotics, ADCs for breast cancer and first pain medication targeting NaV1.8 sodium channel

Samuel Hume, Fellow at The Foulkes Foundation and pursuing PhD in the University of Oxford’s Department of Oncology, shared a post on X:

What new drugs have been FDA-approved so far in 2025?

Among them is an antibiotic with a unique mode-of-action, a new antibody-drug conjugate for breast cancer, and the first pain medication that’s selective for the NaV1.8 sodium channel.”

Samuel Hume

FDA new drug approvals in Q1 2025

Author: Paul Verdin

Samuel Hume

Learn more about new drug developments in oncology on OncoDaily.